Origin: Medical device companies subject to tax under either the personal income tax under M.G.L. c. 62 or a corporate excise under M.G.L. c. 63, and which develop or manufacture medical devices in Massachusetts can claim a transferable credit equal to 100% of the user fees paid by them when submitting certain medical device applications and supplements to the FDA.

The credit may not be carried forward to subsequent tax years and is not refundable. However unused portions of the credit may be transferred and the transferee may carry over the credit but must use it within 5 years.

This particular tax expenditure was enacted on July 8, 2006 making the incentive applicable from tax years beginning on or after January 1, 2006. St. 2006 c. 144 145. The FY22 Budget repeals the credit effective for taxable years beginning on or after January 1, 2022. However, taxpayers will still be able to transfer previously awarded credits and transferees will be able to apply unused amounts of the credit within five years of the credit's transfer.

Origin: M.G.L. c. 63, §31L

Item Number
FY2021
FY2022
FY2023
FY2024
FY2025
2.615
0.5
0.5
Expired
Expired
Expired
Loading...